Researchers at Umeå University, Sweden, have found another piece of the puzzle that explains why there are differences in immune responses in women and men when they get sick with COVID-19. This ...

A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory problems not just from COVID but influenza and other respiratory infections.

Scientists have solved the mystery of unusual blood clotting and inflammation in COVID-19 -- and identified a promising therapeutic strategy. In a study that reshapes what we know about COVID-19 and ...

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...